Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K B Delasalle

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
British Journal of Haematology|December 1, 1994
Primary plasma cell leukaemiaM A Dimopoulos, A Palumbo, K B Delasalle, et al.
British Journal of Haematology|February 1, 1993
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myelomaM A Dimopoulos, K B Delasalle, R Champlin, et al.
Cancer|November 1, 1993
Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myelomaM A Dimopoulos, D Weber, K B Delasalle, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Myeloablative therapy for primary resistant multiple myelomaR Alexanian, M A Dimopoulos, K B Delasalle, et al.
The American Journal of Medicine|January 1, 1993
Risk of disease progression in asymptomatic multiple myelomaM A Dimopoulos, A Moulopoulos, T Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factorsM A Dimopoulos, D Weber, K B Delasalle, et al.
American Journal of Hematology|June 1, 1996
HyperCVAD for VAD-resistant multiple myelomaM A Dimopoulos, D Weber, H Kantarjian, et al.
British Journal of Haematology|June 1, 1997
Prognostic features of asymptomatic multiple myelomaD M Weber, M A Dimopoulos, L A Moulopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myelomaL A Moulopoulos, M A Dimopoulos, T L Smith, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
British Journal of Haematology|December 1, 1994
Primary plasma cell leukaemiaM A Dimopoulos, A Palumbo, K B Delasalle, et al.
British Journal of Haematology|February 1, 1993
Cyclophosphamide and etoposide therapy with GM-CSF for VAD-resistant multiple myelomaM A Dimopoulos, K B Delasalle, R Champlin, et al.
Cancer|November 1, 1993
Combination therapy with interferon-dexamethasone for newly diagnosed patients with multiple myelomaM A Dimopoulos, D Weber, K B Delasalle, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Myeloablative therapy for primary resistant multiple myelomaR Alexanian, M A Dimopoulos, K B Delasalle, et al.
The American Journal of Medicine|January 1, 1993
Risk of disease progression in asymptomatic multiple myelomaM A Dimopoulos, A Moulopoulos, T Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factorsM A Dimopoulos, D Weber, K B Delasalle, et al.
American Journal of Hematology|June 1, 1996
HyperCVAD for VAD-resistant multiple myelomaM A Dimopoulos, D Weber, H Kantarjian, et al.
British Journal of Haematology|June 1, 1997
Prognostic features of asymptomatic multiple myelomaD M Weber, M A Dimopoulos, L A Moulopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myelomaL A Moulopoulos, M A Dimopoulos, T L Smith, et al.
Blood|October 15, 1993
Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myelomaM A Dimopoulos, R Alexanian, D Przepiorka, et al.
Pageof 1